2 recruiting, 1 completed, 1 terminated, 1 unknown. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 2, Completed 1, Terminated 1, Unknown 1 |
Follow Primary Liver Cancer: new trials by email Literature Review of Primary Liver Cancer trials Research Report on Primary Liver Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Y-90 Treatment Response Using Transarterial Radioembolization Lumason, Sonazoid - HCC, Hepatocellular Carcinoma | Phase 2 | Recruiting | Thomas Jefferson University | 30 | 2025-09-11 | 2026-06-10 |
| Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer Stereotactic Body Radiation Therapy (SBRT), Radiofrequency ablation therapy - Primary Liver Cancer | Phase 2 | Recruiting | Tianjin Medical University Cancer Institute and Hospital | 130 | 2025-01-01 | 2025-01-09 |
| RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial Neo-MASCT - Primary Liver Cancer, Radiofrequency Ablation | Phase 2 | Unknown | Sun Yat-sen University | 98 | 2017-07-25 | 2022-01-26 |
| Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation Transarterialchemoembolisation (TACE), DC Bead with Doxorubicin - Primary Liver Cancer | Phase 2 | Completed | Boston Scientific Corporation | 212 | 2005-11-01 | 2021-07-21 |
| Antineoplaston Therapy in Treating Patients With Primary Liver Cancer Antineoplaston therapy (Atengenal + Astugenal) - Primary Liver Cancer | Phase 2 | Terminated | Burzynski Research Institute | 3 | 1977-03-21 | 2017-11-21 |
Carcinoma, Hepatocellular (5) · Carcinoma (1) · Liver Neoplasms (1)
Adenocarcinoma (5) · Digestive System Diseases (5) · Digestive System Neoplasms (5) · Liver Diseases (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms by Site (5) · Neoplasms, Glandular and Epithelial (5) · Carcinoma (4) · Liver Neoplasms (4)
Radiosurgery (1) · antineoplaston A10 (1) · antineoplaston AS 2-1 (1)
Boston Scientific Corporation (1) · Burzynski Research Institute (1) · Sun Yat-sen University (1) · Thomas Jefferson University (1) · Tianjin Medical University Cancer Institute and Hospital (1)
China (2) · United States (2) · Austria (1) · France (1) · Germany (1) · Switzerland (1)
John Eisenbrey, PhD (1) · Ming Kuang, Ph.D. (1) · Prof Johannes Lammer (1) · Stanislaw R. Burzynski, MD, PhD (1)
R21CA303648 (1)